Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108659028B details a novel palladium-catalyzed trans-carboboration method for synthesizing high-purity fluorochemical intermediates with improved supply chain efficiency.
Patent CN112778261B details a mild silver-catalyzed route to isocoumarins, offering cost-effective manufacturing and scalable supply chain solutions.
Patent CN109384789B details a mild Ag(I)-catalyzed route to indoloazepines, offering cost-effective manufacturing for pharmaceutical intermediates.
Patent CN119330863A reveals air-stable synthesis reducing heavy metal use. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity standards.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101735095A details a novel copper-catalyzed oxidative coupling for alpha-carbonyl amides, offering significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Novel DMF-mediated synthesis of trifluoromethyl triazoles via patent CN114920707B. High efficiency, air-stable conditions ideal for API intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel radical cyclization method for benzimidazol[2,1-a]isoquinolin-6(5H)-ones. Efficient route reducing costs in pharmaceutical intermediate manufacturing with high purity.
Patent CN115286553B reveals nickel-catalyzed indole synthesis offering substantial cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114195726B reveals robust CuCl catalyzed route for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones offers high yields and broad substrate scope for reliable pharmaceutical intermediate supply chains.
Patent CN111533706A reveals a copper-catalyzed one-pot method for triazines. Achieve cost reduction in fine chemical manufacturing with air-stable catalysts and high atom economy.
Novel one-step carbonylation cyclization for N-acyl indoles. High efficiency, broad substrate scope, cost-effective API intermediate manufacturing.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles using diazo compounds, offering significant cost and safety advantages.
Novel chiral phosphoric acid catalyzed resolution method for high-purity axially chiral oxindole-substituted styrenes, offering scalable synthesis for pharmaceutical intermediates.
Novel Mo/Cu co-catalyzed method for high-purity triazoles. Reduces steps and improves yield for pharmaceutical manufacturing.
Novel palladium-catalyzed reductive aminocarbonylation method for high-purity quinolinone derivatives, offering scalable routes for pharmaceutical intermediates.
Patent CN114380741B details a green Ag-catalyzed method for 4-alkylated quinolines. Achieves high purity and yield in water, offering significant cost reduction in API manufacturing.